Dr. James Cook has earned a patent which is part of a portfolio of drug compounds targeting the GABAA receptors of the brain and is focused on aiding cognition and depression. Major depressive disorder affects 350 million people globally, ranking as a top cause of disability. Despite this burden, pharmaceutical companies have reduced antidepressant development. Novel antidepressants addressing cognitive dysfunction containing compounds like these are crucial for future treatment. See patent, US11753412B2
Dr. Mark Dietz and team have developed a new research tool for the method for preparation of surface-porous supports. This innovation allows the extraction of metal ions from a mixture. Metal ion separations play a vital role in industrial processes and analytical methods. An example of this is radiochemical separations, which can be used to isolate radioisotopes for medical applications such as imaging and cancer treatment. See patent, US11691140B2